These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 29393428)

  • 21. Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF-
    Jin F; Zhang L; Chen K; Miao Y; Liu Y; Tian Y; Li J
    Biomed Res Int; 2022; 2022():3360771. PubMed ID: 35586807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bufei Yishen formula protects the airway epithelial barrier and ameliorates COPD by enhancing autophagy through the Sirt1/AMPK/Foxo3 signaling pathway.
    Jia L; Liu X; Liu X; Guan Q; Tian Y; Li J; Zhao P
    Chin Med; 2024 Feb; 19(1):32. PubMed ID: 38413976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maintenance of airway epithelial barrier integrity via the inhibition of AHR/EGFR activation ameliorates chronic obstructive pulmonary disease using effective-component combination.
    Wei Y; Liu X; Jiang Y; Guan Q; Tian Y; Li J; Zhao P
    Phytomedicine; 2023 Sep; 118():154980. PubMed ID: 37499344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects and mechanism of bufei yishen formula in a rat chronic obstructive pulmonary disease model.
    Li J; Yang L; Yao Q; Li Y; Tian Y; Li S; Jiang S; Wang Y; Li X; Guo Z
    Evid Based Complement Alternat Med; 2014; 2014():381976. PubMed ID: 24959185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Metabolites and Metabolic Pathways Related to Treatment with Bufei Yishen Formula in a Rat COPD Model Using HPLC Q-TOF/MS.
    Yang L; Li J; Li Y; Tian Y; Li S; Jiang S; Wang Y; Song X
    Evid Based Complement Alternat Med; 2015; 2015():956750. PubMed ID: 26170891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective-component compatibility of Bufei Yishen formula protects COPD rats against PM2.5-induced oxidative stress via miR-155/FOXO3a pathway.
    Li J; Wang J; Li Y; Zhao P; Tian Y; Liu X; He H; Jia R
    Ecotoxicol Environ Saf; 2021 Nov; 228():112918. PubMed ID: 34773846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bupi Yishen formula attenuates kidney injury in 5/6 nephrectomized rats via the tryptophan-kynurenic acid-aryl hydrocarbon receptor pathway.
    Mo Y; Jie X; Wang L; Ji C; Gu Y; Lu Z; Liu X
    BMC Complement Med Ther; 2021 Aug; 21(1):207. PubMed ID: 34376166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bufei Yishen granule combined with acupoint sticking improves pulmonary function and morphormetry in chronic obstructive pulmonary disease rats.
    Tian Y; Li Y; Li J; Xie Y; Wang M; Dong Y; Li L; Mao J; Wang L; Luo S
    BMC Complement Altern Med; 2015 Aug; 15():266. PubMed ID: 26253241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective-compound combination of Bufei Yishen formula III combined with ER suppress airway mucus hypersecretion in COPD rats: via EGFR/MAPK signaling.
    Xu K; Ma J; Lu R; Shao X; Zhao Y; Cui L; Qiu Z; Tian Y; Li J
    Biosci Rep; 2023 Nov; 43(11):. PubMed ID: 36799253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effects of the Bupi Yishen formula on renal fibrosis through PI3K/AKT signaling inhibition.
    Liu B; Deng J; Jie X; Lu F; Liu X; Zhang D
    J Ethnopharmacol; 2022 Jul; 293():115242. PubMed ID: 35367329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation.
    Zhang D; Liu B; Jie X; Deng J; Lu Z; Lu F; Liu X
    Front Pharmacol; 2021; 12():761572. PubMed ID: 34867380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of Tiaobu Feishen therapies on systemic and local inflammation responses in rats with stable chronic obstructive pulmonary disease.
    Li JS; Li Y; Li SY; Wang YY; Deng L; Tian YG; Jiang SL; Wang Y
    Zhong Xi Yi Jie He Xue Bao; 2012 Sep; 10(9):1039-48. PubMed ID: 22979936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptomics and metabolomics revealed the pulmonary protective mechanism of Xixin-Ganjiang Herb Pair for warming the lungs to dissolve phlegm in COPD rats.
    Huang P; Duan B; Li D; Duan Y; Zhou Z; Han L; Li J; Wu J; Ye Y; Zhang F; Guo Z; Wang Q; Huang F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1224():123665. PubMed ID: 37209557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK Pathway.
    Ma J; Liu X; Wei Y; Lu R; Xu K; Tian Y; Li J
    Evid Based Complement Alternat Med; 2022; 2022():9423435. PubMed ID: 36619199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systems pharmacology reveals the mechanism of activity of Ge-Gen-Qin-Lian decoction against LPS-induced acute lung injury: A novel strategy for exploring active components and effective mechanism of TCM formulae.
    Ding Z; Zhong R; Yang Y; Xia T; Wang W; Wang Y; Xing N; Luo Y; Li S; Shang L; Shu Z
    Pharmacol Res; 2020 Jun; 156():104759. PubMed ID: 32200026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective-components combination alleviates PM2.5-induced inflammation by evoking macrophage autophagy in COPD.
    Wang J; He W; Yue H; Zhao P; Li J
    J Ethnopharmacol; 2024 Mar; 321():117537. PubMed ID: 38043756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.
    Zhang Z; Yi P; Yang J; Huang J; Xu P; Hu M; Zhang C; Wang B; Peng W
    J Ethnopharmacol; 2020 Mar; 249():112371. PubMed ID: 31683034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of Xixin-Ganjiang herb pair for warming the lungs to dissolve phlegm in chronic obstructive pulmonary disease rats based on integrated network pharmacology and metabolomics.
    Huang P; Xiang T; Wang Q; Han L; Zheng S; Zhang D; Huang F; Duan B; Li J; Li H; Huang T
    Biomed Chromatogr; 2024 Jun; 38(6):e5851. PubMed ID: 38449348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chinese herbal formula Fuzheng Huayu alleviates CCl
    Dong S; Cai FF; Chen QL; Song YN; Sun Y; Wei B; Li XY; Hu YY; Liu P; Su SB
    Acta Pharmacol Sin; 2018 Jun; 39(6):930-941. PubMed ID: 29094729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Bufei Yishen Granules Combined with Acupoint Sticking Therapy on Pulmonary Surfactant Proteins in Chronic Obstructive Pulmonary Disease Rats.
    Tian Y; Li J; Li Y; Dong Y; Yao F; Mao J; Li L; Wang L; Luo S; Wang M
    Biomed Res Int; 2016; 2016():8786235. PubMed ID: 27699176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.